Dodge & Cox – GSK history
- Issuer:
- GSK PLC
- Quarters tracked:
- 15 (Q3 2022 → Q1 2026)
- Current shares:
- 58,662,974
- Current value:
- $3.24B
- Peak shares:
- 78,757,869 (Q2 2025)
- Overall change:
- 0%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 58,662,974 | $3.24B | $55.19 | -9,854,995 | -14% |
| Q4 2025 | 68,517,969 | $3.36B | $49.04 | -9,885,765 | -13% |
| Q3 2025 | 78,403,734 | $3.38B | $43.16 | -354,135 | 0% |
| Q2 2025 | 78,757,869 | $3.02B | $38.40 | +106,036 | 0% |
| Q1 2025 | 78,651,833 | $3.05B | $38.74 | +10,210,921 | +15% |
| Q4 2024 | 68,440,912 | $2.31B | $33.82 | +353,749 | +1% |
| Q3 2024 | 68,087,163 | $2.78B | $40.88 | -249,975 | 0% |
| Q2 2024 | 68,337,138 | $2.63B | $38.50 | -525,170 | -1% |
| Q1 2024 | 68,862,308 | $2.95B | $42.87 | -164,485 | 0% |
| Q4 2023 | 69,026,793 | $2.56B | $37.06 | -254,390 | 0% |
| Q3 2023 | 69,281,183 | $2.51B | $36.25 | -330,085 | 0% |
| Q2 2023 | 69,611,268 | $2.48B | $35.64 | -95,800 | 0% |
| Q1 2023 | 69,707,068 | $2.48B | $35.58 | +4,774,116 | +7% |
| Q4 2022 | 64,932,952 | $2.28B | $35.14 | +6,348,963 | +11% |
| Q3 2022 | 58,583,989 | $1.72B | $29.43 | — | NEW |